UNASSIGNED: Stereotactic radiosurgery (SRS) has proven to be an effective strategy in the management of @entity7026 (AVMs) in @entity1 and adults over the past three decades. Its application has resulted in lowering the morbidity and mortality associated with treatment of @entity2758 . SRS has been used as a primary modality of therapy as well as in conjunction with embolization and microsurgery in the management of AVMs. The obliteration rate after SRS has been reported to range from 35% to 92%. Smaller AVMs receiving higher marginal doses have obliteration rates of 70% and more. The median follow-up reported in most series is approximately 36-40 months. The median time to obliteration has been reported to be approximately 24-36 months in most series. Radiation-induced @entity16 have been reported in less than 10% of @entity1 , with a 1.5%-6% risk of developing a new permanent @entity51 . The @entity548 rate during the latency to obliteration has been reported to be approximately 5%. This review describes the experience reported in literature with respect to the indications, dosage, factors affecting obliteration rate of AVMs, and complications after SRS.

Stereotactic radiosurgery for XXXX : A review.

@entity1 :: ('9606', 'Species') :: ['children', 'patients'] @entity7026 :: ('MESH:D002538', 'Disease') :: ['intracranial arteriovenous malformations'] @entity2758 :: ('MESH:D001165', 'Disease') :: ['deep-seated AVMs'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity16 :: ('MESH:D009422', 'Disease') :: ['neurological complications'] @entity51 :: ('MESH:D009461', 'Disease') :: ['neurological deficit']
@entity7026 :: (MESH:D002538,Disease) :: ['intracranial arteriovenous malformations']
